5,909
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1563-1570 | Received 14 Sep 2020, Accepted 05 Nov 2020, Published online: 21 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Priyanka Purohit, Jiban Jyoti Dash, Jules Tshishimbi Muya & Biswa Ranjan Meher. (2023) Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 Mpro: an in silico approach towards drug repurposing. Journal of Biomolecular Structure and Dynamics 41:9, pages 3900-3913.
Read now
Mountasser Douma, Brahim Boualy, Najat Manaut, Redouan Hammal, Said Byadi, Meryem Lahlali, Fatima-Ezzahra Eddaoudi & Siham Mallouk. (2021) Sulphated polysaccharides from seaweeds as potential entry inhibitors and vaccine adjuvants against SARS-CoV-2 RBD spike protein: a computational approach. Journal of Taibah University for Science 15:1, pages 649-655.
Read now

Articles from other publishers (9)

Unnati Patel, Krishna Desai, Ranjitsinh C. Dabhi, Jayesh J. Maru & Pranav S. Shrivastav. (2023) Bioprospecting phytochemicals of Rosmarinus officinalis L. for targeting SARS-CoV-2 main protease (Mpro): a computational study. Journal of Molecular Modeling 29:5.
Crossref
Aparupa Bose Mazumdar Ghosh, Anindita Banerjee & Sharmila Chattopadhyay. (2022) An insight into the potent medicinal plant Phyllanthus amarus Schum. and Thonn.. The Nucleus 65:3, pages 437-472.
Crossref
Farak Ali, Shahnaz Alom, Anshul Shakya, Surajit K. Ghosh, Udaya P. Singh & Hans R. Bhat. (2022) Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2. Archiv der Pharmazie 355:5.
Crossref
Firdayani, A Riswoko & I Helianti. (2022) Inhibition of SARS-Cov-2 proteases by medicinal plant bioactive constituents: Molecular docking simulation. IOP Conference Series: Earth and Environmental Science 976:1, pages 012054.
Crossref
Deepak Timalsina, Deepti Bhusal, Hari Prasad Devkota, Krishna Prasad Pokhrel & Khaga Raj Sharma. (2021) α-Amylase Inhibitory Activity of Catunaregam spinosa (Thunb.) Tirveng.: In Vitro and In Silico Studies. BioMed Research International 2021, pages 1-11.
Crossref
Nizami Duran, M. Fatih Polat, Derya Anil Aktas, M. Abdullah Alagoz, Emrah Ay, Funda Cimen, Erhan Tek, Baris Anil, Serdar Burmaoglu & Oztekin Algul. (2021) New chalcone derivatives as effective against SARS‐CoV‐2 agent. International Journal of Clinical Practice 75:12.
Crossref
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Marcos Loroño, J.L. Paz, Laura Jeffreys & Ysaias J. Alvarado. (2021) Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach. Biophysical Chemistry 278, pages 106677.
Crossref
Kaushik Kumar Bharadwaj, Tanmay Sarkar, Arabinda Ghosh, Debabrat Baishya, Bijuli Rabha, Manasa Kumar Panda, Bryan Raveen Nelson, Akbar B. John, Hassan I. Sheikh, Bisnu Prasad Dash, Hisham Atan Edinur & Siddhartha Pati. (2021) Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 Mpro: Bioinformatics Approach. Applied Biochemistry and Biotechnology 193:10, pages 3371-3394.
Crossref
Muthumanickam Sankar, Balajee Ramachandran, Boomi Pandi, Nachiappan Mutharasappan, Vidhyavathi Ramasamy, Poorani Gurumallesh Prabu, Gowrishankar Shanmugaraj, Yao Wang, Brintha Muniyandai, Subaskumar Rathinasamy, Balakumar Chandrasekaran, Mohammad F. Bayan, Jeyakanthan Jeyaraman, Gurumallesh Prabu Halliah & Solomon King Ebenezer. (2021) In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19. Frontiers in Molecular Biosciences 8.
Crossref